This is a snippet of the transcript.Contact Salesto get full access.
There are two competitive differentiators. The biggest one is what's called an inter-laboratory comparison. For instance, if I get 4%, the lab down the road gets 3.9%, and the doctor's office gets 5.4%, all those values over a month's time are sent to a central server that Bio-Rad has run for the last 30 years. They perform statistical analysis and tell you whether your laboratory, with that same bottle of control and lot number, is on or off. If your laboratory reads 5.5%, it might be a statistical outlier, indicating your machines might be systematically out of calibration.
This is a snippet of the transcript.Contact Salesto get full access.
This helps with laboratory inspections. They have to participate in some clinical program. I don't know if you've heard of the CAP surveys, but this is a mini, ongoing version of the CAP survey. The College of American Pathologists sends out similar samples to laboratories for accrediting each quarter. This is how laboratories ensure they pass their CAP surveys because they have to get the right number. They know they'll get the right number on the CAP survey because they're using Bio-Rad controls to ensure the machine's accuracy.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.